health technology assessment emerging countries
60 views | +0 today
Follow
Your new post is loading...
Your new post is loading...
Scooped by Marcus Healey
Scoop.it!

Launch webinar - The Impact of AMNOG on Pricing and Reimbursement

Webinar 27 Jan 2014: Introducing this essential resource -- The Impact of AMNOG on Pricing and Reimbursement in Germany and Beyond. Register at: www.prmacons...
Marcus Healey's insight:

Monika elucidates AMNOG to eager DE HTA watchers.

more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

New EU plan to fast-track next-generation drugs launches - PharmaTimes

New EU plan to fast-track next-generation drugs launches - PharmaTimes | health technology assessment emerging countries | Scoop.it
New EU plan to fast-track next-generation drugs launches
PharmaTimes
The project will aim to advance understanding of the condition and address the lack of tools and technologies to detect people's risk of developing it.
more...
Marcus Healey's curator insight, July 9, 2014 4:12 PM

Innovative Medicines Initiative 2. Focus high unmet/societal need: diabetes and retinal diseases. Unsurprising given run up to projected 400 mn people living with diabetes worldwide and impt of trmnts for retinal diseases.

Scooped by Marcus Healey
Scoop.it!

Building a Technology Assessment Program

ECRI Institute can help hospitals and health systems determine if the medical equipment they're considering will bring value to their organization based on t...
more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

Wearable Diagnostic Tool Improves Vital Sign Readings

Intel Health and Life Sciences General Manager Eric Dishman sits down with Gunnar Trommer, Ph. D., Vice President, Marketing and Business Development at Sote...
more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

Transformative Innovation in Healthcare -- A Large Payer's View

Kicking off the 2013 Healthcare Growth Cap Conference on April 11, 2013, CEO for Healthagen, Charles Saunders, MD, delivers the Opening Keynote Address. Pres...
more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

European Pharma Policy Reaches "New Level of Timidity" - PharmExec.com (blog)

European Pharma Policy Reaches "New Level of Timidity" PharmExec.com (blog) But with the emergence of rival health technology assessment methods across Europe, “diverging requirements between Member States can lead to shortcomings in the efficient...
more...
Marcus Healey's curator insight, July 9, 2014 4:44 PM

EU, once again, snatching defeat from jaws of victory by organizing another meeting for industry insiders and stakeholders about ways to boost the drug industry. In the eyes of veteran EU pharma policy observers this was another instance where EU officials sunk to new levels of pusillanimity and timidity about ways to boost an industry with access challenges occur along the value chain from discovery of a medicine to the use by the patient.

Scooped by Marcus Healey
Scoop.it!

Exeter Seminar: Chris Hyde - innovation and diagnostic technologies

Professor Chris Hyde (Institute for Health Services Research, University of Exeter Medical School) reflects on the promise and challenges of novel diagnostic...
more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

La professione di chi lavora nell'Health Technology Assessment

Intervista alla Dr.ssa Lara Pippo, Payers & Evidence Solutions Manager di GlaxoSmithKLine.
more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

Outcome Report on European Collaboration between Regulators and HTA Bodies - Pharmaceutical Technology Magazine (blog)

Outcome Report on European Collaboration between Regulators and HTA Bodies Pharmaceutical Technology Magazine (blog) In addition, EMA and EUnetHTA will continue to explore other areas of collaboration or exchange of information, such as ways for...
more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

Outcome report on first European collaboration between regulators and HTA ... - The Pharma Letter

Outcome report on first European collaboration between regulators and HTA ... - The Pharma Letter | health technology assessment emerging countries | Scoop.it
Outcome report on first European collaboration between regulators and HTA ...
more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

HTA in the UK and the EU

Jérôme Boehm, Policy co-ordinator, Team Leader, European Commission DG SANCO, outlines what the European Commission would like to see: sharing, exchanging an...
more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

CER and HTA: A View From the UK

Dr. Michael Drummond, professor of Health Economics at the University of York, UK, explains the differences between health technology assessments (HTA) and c...
more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

DIA 2012 - The Effects of NICE Technology Assessments on Cost-Sharing Behavior in the US

John Doyle, Practice Leader of Market Access for Consulting at Quintiles, will appear on a panel at DIA 2012: "The Effects of NICE Technology Assessments on ...
more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

Collaboration Between Regulators and HTA Organizations to Improve Health ... - GlobeNewswire (press release)

Collaboration Between Regulators and HTA Organizations to Improve Health ... - GlobeNewswire (press release) | health technology assessment emerging countries | Scoop.it
Collaboration Between Regulators and HTA Organizations to Improve Health ...
more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

Current and Future Access Challenges for Specialty and Biotechnology Products

Watch the entire webinar by registering for free at: http://xtalks.com/Access-Challenges-Specialty-Biotechnology-Products.ashx?utm_source=Youtube&utm_medium=...
more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

Cost-effectiveness in healthcare: how devices & diagnostics help

Top European Commission health official Paola Testori Coggi talks about how in vitro diagnostics and medical devices contribute to cost-effectiveness in Euro...
more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

HEALTHCARE -- Data Policy & Economics ( 8:45am May 14th)

Increasing costs and delivery expectations, rapidly emerging technologies and continuing questions about sustainability and the quality of healthcare continu...
more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

AGreenRoad - Dr. Himmelstein MD - Health Vs Profits - US System Vs Canadian Single Payer System

A speech of a David Himmelstein MD-- medical doctor from Harvard Medical School who shows the deficiencies of a for profit health plan and compares it to the...
more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

The Not So Hidden Costs Of An Internet Of Things - Forbes

The Not So Hidden Costs Of An Internet Of Things - Forbes | health technology assessment emerging countries | Scoop.it
Forbes
The Not So Hidden Costs Of An Internet Of Things
Forbes
Watches with built-in navigation, thermostats that know when you're home, programmable light bulbs, and hoodies that can send texts.
more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

Session 5: HTA of Companion diagnostics

Session 5: Pharmacogenomics: impact and needs from health care view point to facilitate patients' access Speaker: Elisabeth George, National Institute for He...
more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

2013 CADTH Symposium: Dr. Murray Krahn

Dr. Murray Krahn shares his "big idea in HTA" at the 2013 CADTH Symposium closing plenary. His idea is early health technology assessment -- bringing togethe...
more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

HTA

Jérôme Boehm, Policy co-ordinator, Team Leader, European Commission DG SANCO, explains what Health Technology Assessment (HTA) is. Prof. Bruce Campbell, Comm...
more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

Jürgen Windeler on the future of HTA in Germany (ISPOR Berlin 2012)

Jürgen Windeler, Director of IQWiG, Germany's health technology assessment body, talked to Pin Lu of Rx Communications about the future of HTA in Germany. Cu...
more...
No comment yet.
Scooped by Marcus Healey
Scoop.it!

A Payer Tool for Considering Individual Treatment Effects

Dr. Jennifer Graff, director of Comparative Effectiveness Research at the National Pharmaceutical Council, explains that payers are often faced with making c...
more...
No comment yet.